Location History:
- Torslanda, SE (2003 - 2006)
- Mölndal, SE (2010)
Company Filing History:
Years Active: 2003-2010
Title: Thomas Olsson: Innovator in Gastrointestinal Treatments
Introduction
Thomas Olsson is a notable inventor based in Torslanda, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for gastrointestinal disorders. With a total of 3 patents, his work focuses on innovative compounds that modulate GABA receptors.
Latest Patents
One of Olsson's latest patents is centered around imidazole variants as modulators of the GABA receptor for the treatment of gastrointestinal disorders. This invention relates to novel compounds that exhibit a positive allosteric GABAB receptor modulator effect. The methods for preparing these compounds and their applications include the inhibition of transient lower esophageal sphincter relaxations, which is crucial for treating gastroesophageal reflux disease, functional gastrointestinal disorders, and irritable bowel syndrome (IBS). Another patent involves aminopropylphosphinic acids, which serve as intermediates in the preparation of compounds of a specific formula, excluding certain racemates and stereoisomers.
Career Highlights
Throughout his career, Thomas Olsson has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Sortina Pharma AB. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Olsson has collaborated with notable colleagues such as Thomas Elebring and Peter Guzzo. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
Thomas Olsson's work in the field of gastrointestinal treatments showcases his dedication to innovation and improvement in healthcare. His patents reflect a commitment to developing effective solutions for complex medical issues.